Michael Sacherer
Overview
Explore the profile of Michael Sacherer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
von Lewinski F, Quehenberger F, Sacherer M, Taucher V, Strohhofer C, Ablasser K, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685783
Ambient air pollution is a significant public health concern, known to affect cardiovascular health adversely. Research has identified both long-term and short-term cardiovascular risks associated with various air pollutants, including...
2.
von Lewinski D, Herold L, Bachl E, Bugger H, Glantschnig T, Kolesnik E, et al.
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002602
Background: Cardiogenic shock (CS) exhibits high (~50%) in-hospital mortality. The recently published Extracorporeal life Support in Cardiogenic Shock (ECLS-SHOCK) trial demonstrated the neutral effects of the use of veno-arterial extracorporeal...
3.
Ljubojevic-Holzer S, Herren A, Djalinac N, Voglhuber J, Morotti S, Holzer M, et al.
Circ Res
. 2020 Aug;
127(9):1159-1178.
PMID: 32821022
Rationale: CaMKII (Ca-Calmodulin dependent protein kinase) δC activation is implicated in pathological progression of heart failure (HF) and CaMKIIδC transgenic mice rapidly develop HF and arrhythmias. However, little is known...
4.
Berulava T, Buchholz E, Elerdashvili V, Pena T, Islam M, Lbik D, et al.
Eur J Heart Fail
. 2019 Dec;
22(1):54-66.
PMID: 31849158
Aims: Deregulation of epigenetic processes and aberrant gene expression are important mechanisms in heart failure. Here we studied the potential relevance of m6A RNA methylation in heart failure development. Methods...
5.
Mokou M, Klein J, Makridakis M, Bitsika V, Bascands J, Saulnier-Blache J, et al.
EBioMedicine
. 2019 Mar;
41:91-104.
PMID: 30826357
Background: The increased prevalence of cardiovascular disease (CVD) indicates a demand for novel therapeutic approaches. Proteome analysis of vascular tissues from animal models and humans with CVD could lead to...
6.
Pruller F, Bis L, Milke O, Fruhwald F, Patzold S, Altmanninger-Sock S, et al.
J Clin Med
. 2018 Nov;
7(11).
PMID: 30445678
Dual antiplatelet therapy is the standard of care for patients with myocardial infarction (MI), who have been resuscitated and treated with therapeutic hypothermia (TH). We compare the antiplatelet effect and...
7.
Voelkl J, Luong T, Tuffaha R, Musculus K, Auer T, Lian X, et al.
J Clin Invest
. 2018 Jun;
128(7):3024-3040.
PMID: 29889103
Medial vascular calcification, associated with enhanced mortality in chronic kidney disease (CKD), is fostered by osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs). Here, we describe that serum- and glucocorticoid-inducible...
8.
Sacherer M, Kolesnik E, von Lewinski F, Verheyen N, Brandner K, Wallner M, et al.
Cardiol J
. 2018 Apr;
26(3):233-240.
PMID: 29611164
Background: Devices currently used to achieve hemostasis of the femoral artery following percutaneous cardiac catheterization are associated with vascular complications and remnants of artificial materials are retained at the puncture...
9.
Alesutan I, Voelkl J, Feger M, Kratschmar D, Castor T, Mia S, et al.
Sci Rep
. 2017 May;
7(1):2059.
PMID: 28515448
Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive osteogenic transformation of vascular smooth muscle cells (VSMCs)....
10.
Sommer G, Schriefl A, Andra M, Sacherer M, Viertler C, Wolinski H, et al.
Acta Biomater
. 2015 Jul;
24:172-92.
PMID: 26141152
Statement Of Significance: Unfortunately, to date there are no experimental data of human heart tissues available for material parameter estimation and the development of adequate material models. In this manuscript...